Mercer Global Advisors Inc Novavax Inc Transaction History

Mercer Global Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$36.28 - $75.29 $106,953 - $221,954	-2,948 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$69.73 - $142.9 $44,069 - $90,312	632 Added 27.29%	2,948 $217,000
Q4 2021 Feb 04, 2022	SELL	$134.56 - $217.97 $57,053 - $92,419	-424 Reduced 15.47%	2,316 $331,000
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $135,305 - $205,911	761 Added 38.45%	2,740 $568,000
Q2 2021 Aug 10, 2021	BUY	$121.0 - $257.67 $239,459 - $509,928	1,979 New	1,979 $420,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $729M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.